Back to Browse Journals » Clinical Interventions in Aging » Volume 3 » Issue 2

Clinical challenges in the management of osteoporosis

Authors Sheryl F Vondracek, Paul Minne, Michael T McDermott

Published 6 June 2008 Volume 2008:3(2) Pages 315—329

DOI http://dx.doi.org/10.2147/CIA.S2539

Sheryl F Vondracek1, Paul Minne2, Michael T McDermott3

1Department of Clinical Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA; 2Amgen Medical Affairs, Denver, CO, USA; 3Director of the Endocrine and Diabetes Practice, Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA

Abstract: While knowledge regarding the diagnosis and treatment of osteoporosis has expanded dramatically over the last few years, gaps in knowledge still exist with guidance lacking on the appropriate management of several common clinical scenarios. This article uses fictional clinical scenarios to help answer three challenging questions commonly encountered in clinical practice. The first clinical challenge is when to initiate drug therapy in a patient with low bone density. It is estimated that 34 million Americans have low bone density and are at a higher risk for low trauma fractures. Limitations of using bone mineral density alone for drug therapy decisions, absolute risk assessment and evidence for the cost-effectiveness of therapy in this population are presented. The second clinical challenge is the prevention and treatment of vitamin D deficiency. Appropriate definitions for vitamin D insufficiency and deficiency, the populations at risk for low vitamin, potential consequences of low vitamin D, and how to manage a patient with low vitamin D are reviewed. The third clinical challenge is how to manage a patient receiving drug therapy for osteoporosis who has been deemed a potential treatment failure. How to define treatment failure, common causes of treatment failure, and the approach to the management of a patient who is not responding to appropriate osteoporosis therapy are discussed.

Keywords: osteoporosis, osteopenia, bisphosphonate, vitamin D, dual-energy X-ray absorptiometry

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease

Sheryl F Vondracek, Norbert F Voelkel, Michael T McDermott, Connie Valdez

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:267-277

Published Date: 13 July 2009

Readers of this article also read:

Quantification and localization of M2 macrophages in human kidneys with acute tubular injury

Palmer MB, Vichot AA, Cantley LG, Moeckel GW

International Journal of Nephrology and Renovascular Disease 2014, 7:415-419

Published Date: 7 November 2014

Fullerene–biomolecule conjugates and their biomedicinal applications

Yang X, Ebrahimi A, Li J, Cui Q

International Journal of Nanomedicine 2014, 9:77-92

Published Date: 18 December 2013

Biodistribution, kinetics, and biological fate of SPION microbubbles in the rat

Barrefelt A, Saghafian M, Kuiper R, Ye F, Egri G, Klickermann M, Brismar TB, Aspelin P, Muhammed M, Dähne L, Hassan M

International Journal of Nanomedicine 2013, 8:3241-3254

Published Date: 26 August 2013

Insight into 144 patients with ocular vascular events during VEGF antagonist injections

Mansour AM, Shahin M, Kofoed PK, Parodi MB, Shami M, Schwartz SG

Clinical Ophthalmology 2012, 6:343-363

Published Date: 6 March 2012

The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation

Santos-Martinez MJ, Inkielewicz-Stepniak I, Medina C, Rahme K, D'Arcy DM, Fox D, Holmes JD, Zhang H, Radomski MW

International Journal of Nanomedicine 2012, 7:243-255

Published Date: 13 January 2012

An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease

Sony Mathews, Ashley Reid, Chenlu Tian, et al

Clinical and Experimental Gastroenterology 2010, 3:11-16

Published Date: 20 January 2010

Clinical presentation of anxiety among patients with epilepsy

M López-Gómez, M Espinola, J Ramirez-Bermudez, I E Martinez-Juarez, A L Sosa

Neuropsychiatric Disease and Treatment 2008, 4:1235-1239

Published Date: 5 December 2008

Corrigendum

Dove Medical Press Editorial

Clinical Interventions in Aging 2008, 3:397-397

Published Date: 6 June 2008

Update on the use of pramipexole in the treatment of Parkinson’s disease

Radu Constantinescu

Neuropsychiatric Disease and Treatment 2008, 4:337-352

Published Date: 11 April 2008